Impact of integrated district level mental health care on clinical and social outcomes of people with severe mental illness in rural Ethiopia: an intervention cohort study by Hanlon, C et al.
Impact of integrated district level mental health care on 
clinical and social outcomes of people with severe mental 
illness in rural Ethiopia: an intervention cohort study
Article  (Accepted Version)
http://sro.sussex.ac.uk
Hanlon, C, Medhin, G, Selmau, M, Birhane, R, Dewey, M, Tirfessa, K, Garman, E, Asher, L, 
Thornicroft, G, Patel, V, Lund, C, Prince, M and Fekadu, A (2019) Impact of integrated district 
level mental health care on clinical and social outcomes of people with severe mental illness in 
rural Ethiopia: an intervention cohort study. Epidemiology and Psychiatric Sciences. pp. 1-10. 
ISSN 2045-7960 
This version is available from Sussex Research Online: http://sro.sussex.ac.uk/id/eprint/85045/
This document is made available in accordance with publisher policies and may differ from the 
published  version or from the version of record. If you wish to cite this item you are advised to 
consult the publisher’s version. Please see the URL above for details on accessing the published 
version. 
Copyright and reuse: 
Sussex Research Online is a digital repository of the research output of the University.
Copyright and all moral rights to the version of the paper presented here belong to the individual 
author(s) and/or other copyright owners.  To the extent reasonable and practicable, the material 
made available in SRO has been checked for eligibility before being made available. 
Copies of full text items generally can be reproduced, displayed or performed and given to third 
parties in any format or medium for personal research or study, educational, or not-for-profit 
purposes without prior permission or charge, provided that the authors, title and full bibliographic 
details are credited, a hyperlink and/or URL is given for the original metadata page and the 
content is not changed in any way. 
Accepted by Epidemiology and Psychiatric Sciences 1 
https://www.cambridge.org/core/journals/epidemiology-and-psychiatric-sciences 2 
 3 
Impact of integrated district level mental health care on clinical and social outcomes of people with 4 
severe mental illness in rural Ethiopia: an intervention cohort study 5 
C. Hanlon1,2,3*, G. Medhin4, M. Selamu2, R. Birhane2, M. Dewey1, K. Tirfessa5, E. Garman6, L. Asher7, G. 6 
Thornicroft1, V. Patel8,9,10, C. Lund1,6, M. Prince1, A. Fekadu2,3,11 7 
 8 
Short title: District mental health care for people with SMI in Ethiopia 9 
 10 
Affiliations 11 
1King’s College London, Institute of Psychiatry, Psychology and Neuroscience, Health Service and 12 
Population Research Department, Centre for Global Mental Health 13 
2Addis Ababa University, College of Health Sciences, School of Medicine, Department of Psychiatry, 14 
Addis Ababa, Ethiopia 15 
3Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of 16 
Health Sciences, Addis Ababa University 17 
4Addis Ababa University, Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, 18 
Ethiopia. 19 
5Kotebe Metropolitan University, College of Education and Behavioral Studies, Addis Ababa, Ethiopia 20 
6Alan J Flisher Centre for Public Mental Health, Department of Psychiatry and Mental Health, University 21 
of Cape Town, Cape Town, Republic of South Africa  22 
7University of Nottingham, School of Medicine, Division of Epidemiology and Public Health, Nottingham, 23 
UK 24 
8Harvard Medical School, Department of Global Health and Social Medicine, USA 25 
9Harvard TH Chan School of Public Health, Department of Global Health and Population, USA 26 
                                                          
* Department of Psychiatry, 6th Floor, College of Health Sciences Building, Tikur Anbessa Hospital Compound, PO 
9086, Addis Ababa, Ethiopia 
10Sangath Non-Governmental Organisation, Goa, India 27 
11Global Health & Infection Department, Brighton and Sussex Medical School, Brighton, UK  28 
 29 
Word count: 4000 words 30 
31 
Abstract 32 
Aim 33 
There is limited evidence of the safety and impact of task-shared care for people with severe mental 34 
illnesses (SMI; psychotic disorders and bipolar disorder) in low-income countries. The aim of this study 35 
was to evaluate the safety and impact of a district level plan for task-shared mental health care on 6 and 36 
12-month clinical and social outcomes of people with SMI in rural southern Ethiopia. 37 
Methods 38 
In the Programme for Improving Mental health carE (PRIME), we conducted an intervention cohort 39 
study. Trained primary healthcare (PHC) workers assessed community referrals, diagnosed SMI and 40 
initiated treatment, with independent research diagnostic assessments by psychiatric nurses. Primary 41 
outcomes were symptom severity and disability. Secondary outcomes included discrimination and 42 
restraint.  43 
Results 44 
Almost all (94.5%) PHC worker diagnoses of SMI were verified by psychiatric nurses. All prescribing was 45 
within recommended dose limits.  46 
A total of 245 (81.7%) people with SMI were re-assessed at 12 months. Minimally adequate treatment 47 
was received by 29.8%.   48 
All clinical and social outcomes improved significantly. The impact on disability (standardised mean 49 
difference 0.50; 95% confidence interval (CI) 0.35, 0.65) was greater than impact on symptom severity 50 
(standardised mean difference 0.28; 95%CI 0.13, 0.44). Being restrained in the previous 12 months 51 
reduced from 25.3% to 10.6%, and discrimination scores reduced significantly.  52 
Conclusions 53 
An integrated district level mental health care plan employing task-sharing safely addressed the large 54 
treatment gap for people with SMI in a rural, low-income country setting. Randomised controlled trials 55 
of differing models of task-shared care for people with SMI are warranted.  56 
 57 
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Introduction 64 
The treatment gap for people with severe mental illness (SMI) is over 90% in most low-income countries 65 
(Wang et al., 2007). A ‘full’ task-sharing model whereby primary healthcare (PHC) workers are equipped 66 
to deliver all aspects of first-line mental health care, with limited specialist support, is recommended to 67 
increase access to care. Full task-sharing is at the heart of the World Health Organisation (WHO)’s 68 
mental health Gap Action Programme (mhGAP) (World Health Organization, 2008). However, many 69 
studies of task-shared care for SMI have employed a model whereby a mental health specialist makes 70 
the diagnosis of SMI, initiates treatment and provides ongoing review, combined with involvement of 71 
non-specialists in delivering psychosocial aspects of care (Chatterjee et al., 2014). This ‘partial’ model of 72 
task-sharing cannot address the needs of most people with SMI in low-income countries due to the 73 
scarcity of mental health professionals. In the few examples of programmes employing a ‘full’ task-74 
sharing approach (Gureje et al., 2015, Ventevogel et al., 2012), there is only limited evidence on 75 
whether care can be delivered safely and with sufficient quality to bring about improved outcomes for 76 
people with SMD (Jordans et al., 2017, Jordans et al., 2019). This lack of evidence may be fuelling 77 
reluctance to embrace the more ambitious task-sharing approach (Hanlon et al., 2016b). To address this 78 
evidence gap, we present findings from the Programme for Improving Mental health carE (PRIME) 79 
(Fekadu et al., 2016). We have shown that PRIME in Ethiopia achieved contact coverage of over 80% for 80 
people with SMI in the target population (Hailemariam et al., 2018). The objective of the current study 81 
was to investigate the impact of implementing a district level mental health care plan on the 12-month 82 
clinical and social outcomes of people with SMI who engaged with primary mental health care in 83 
Ethiopia.  84 
 85 
Methods 86 
Study design 87 
We conducted an intervention cohort study, with assessments conducted at the baseline of 88 
implementation of the district mental health care plan (T0), and six (T1) and 12 months (T2) after initial 89 
engagement of people with SMI in the new integrated service. 90 
Setting 91 
The PRIME study was carried out in Sodo district, in the Gurage Zone of the Southern Nations, 92 
Nationalities and Peoples’ Region of southern Ethiopia from December 2014 to July 2016. Sodo has an 93 
estimated population of around 160,000 people (Hanlon et al., 2014). More than 90% of inhabitants live 94 
in rural areas and rely on subsistence farming and small-scale trading. At the time of the study, health 95 
services in Sodo comprised 54 health posts, most of which were staffed by two community health 96 
extension workers with one year of training in general health promotion and illness prevention, and 97 
eight health centres, staffed by nurses, health officers and midwives, who provide basic curative and 98 
obstetric care. There were no doctors or mental health specialists in the district. In the nearest town of 99 
Butajira, located 30 to 50km from Sodo, there was a psychiatric nurse-led out-patient clinic. The nearest 100 
in-patient mental health services were 100-120km away in the capital city, Addis Ababa.     101 
 102 
Sample and recruitment procedures 103 
As described previously (Baron et al., 2018), people with possible SMI in the community were identified 104 
by community key informants and health extension workers who had received half a day of training in 105 
typical presentations of SMI (Shibre et al., 2002). People with possible SMI were referred to the nearest 106 
health centre and assessed by PHC workers who had been trained in mental health care for a total of 10 107 
days: five days of classroom-based teaching using adapted mhGAP training materials and five days of 108 
practical clinical training in the Butajira psychiatric clinic. The PHC workers assessed the referrals, made 109 
a diagnosis of SMI and initiated treatment according to the evidence-based clinical guidelines in the 110 
WHO mhGAP Intervention Guide (World Health Organization, 2016). Independent diagnostic review was 111 
carried out with standardised, semi-structured clinical assessments by research psychiatric nurses using 112 
the OPerational CRITeria for research (OPCRIT) (McGuffin P et al., 1991). Diagnostic assessments were 113 
conducted for all people with PHC worker-diagnosed SMI and wherever the PHC worker was uncertain 114 
about the diagnosis. The research psychiatric nurses reviewed the initial treatment plan. Any changes 115 
made by the psychiatric nurses were communicated back to the PHC workers.  116 
Eligibility criteria 117 
• Confirmatory research psychiatric nurse diagnosis of a psychotic disorder (including 118 
schizophrenia, schizoaffective disorder and depression with psychotic features) or bipolar 119 
disorder. 120 
• Providing informed consent, or caregiver permission, to participate in the study if the person 121 
with SMI lacked capacity to consent.  122 
• Able to converse in Amharic, the official language of the region. 123 
• Planning to reside in the district for at least 12 months. 124 
• No cognitive or sensory impairment that interfered substantially with the clinical assessment.  125 
• Not acutely physically unwell.  126 
Sample size 127 
The sample size for the PRIME SMI cohorts across countries was calculated to detect a 20% reduction in 128 
severity of symptoms at 12 months, with 90% power, two-sided alpha of 0.05 and 20% attrition rate 129 
(Baron et al., 2018), leading to a target sample size of 150. However, in the Ethiopia district, all people 130 
who received a confirmatory diagnosis of SMI were included to establish a completely ascertained 131 
population cohort.   132 
 133 
PRIME intervention for people with SMI 134 
The integrated district mental health care plan for the Ethiopian setting has been described in detail 135 
previously (Fekadu et al., 2016), and involved interventions at the level of the health system, PHC facility 136 
and community.  137 
Health system interventions 138 
The district health office staff were involved in participatory planning using Theory of Change 139 
methodology (Hailemariam et al., 2015). The district health office assigned a focal person for mental 140 
health co-ordination. PRIME provided ongoing technical support with medication supply management 141 
(including establishing a revolving drug fund and providing assistance with forecasting the amount of 142 
psychotropic medication required), building capacity in supervision of mental healthcare (training high-143 
performing general health workers to supervise mental health care) and monitoring and evaluation 144 
activities (e.g. aggregating data on facility contacts and feeding back at the advisory board meetings).  145 
PHC facility interventions 146 
All frontline PHC workers in Sodo district (n=128) were trained in mental healthcare. The PHC workers 147 
received monthly supervision from a psychiatric nurse trained using the mhGAP supervisor training 148 
manual. For rural health centres, supervision was conducted by telephone when weather conditions 149 
precluded travel to the facility. PHC workers could also consult the psychiatric nurse for advice.  People 150 
with confirmed SMI were prescribed an antipsychotic and/or antidepressant medication and/or a 151 
benzodiazepine, as indicated. There were no mood-stabiliser medications available, so people with 152 
bipolar disorder received antipsychotic medication as per usual practice in this setting (Fekadu et al., 153 
2015). Almost all service users had to pay for medication.  154 
In addition to prescription of medication, PHC workers were trained to provide psychoeducation, 155 
activate social supports, address social stressors, monitor physical health, review response to treatment 156 
and refer to specialist mental health care if needed. As prescriptions were usually for a maximum of one 157 
month, follow-up appointments with the PHC workers were usually scheduled monthly.  158 
Community level interventions 159 
A multi-sectoral ‘community advisory board’ was established to support community awareness-raising 160 
and mobilisation, to help with trouble-shooting during the implementation phase and to review project 161 
activities and outcomes. A total of 96 community-based health extension workers were trained in case 162 
detection, outreach to re-engage people who dropped out of care, identification of medication side 163 
effects, community awareness-raising and supporting social reintegration and recovery of people with 164 
SMI. In half of the sub-districts, people with schizophrenia who had enduring symptoms or disability 165 
after six months received adjuvant community-based rehabilitation, delivered by trained lay workers 166 
(n=75) or ongoing PRIME care (n=87), as part of a nested cluster randomised trial (the RISE trial) (Asher 167 
et al., 2016). Aside from the additional contacts from CBR workers in the intervention arm (weekly for 168 
two to three months and two-weekly for the subsequent five to six months), there were no additional 169 
trial-related contacts.  170 
 171 
Measures 172 
Primary outcomes 173 
• Clinical symptom severity was measured using the Brief Psychiatric Rating Scale, expanded 174 
version (BPRS-E) (Burlingame et al., 2006). The BPRS-E is a 24-item, clinician-rated scale which 175 
has been translated into Amharic and shown to have robust psychometric properties and 176 
sensitivity to change in Ethiopia (Habtamu et al., 2017).  177 
• Disability was measured using the World Health Organisation Disability Assessment Schedule 178 
(WHODAS), version 2.0, 36-item version (Üstün et al., 2010). The WHODAS has been validated 179 
for use in people with SMI in Ethiopia and is sensitive to change (Habtamu et al., 2017). The 180 
WHODAS was completed by a combination of responses from the person with SMI and the 181 
caregiver responses to the proxy-WHODAS at the post-baseline assessments (19.8% of WHODAS 182 
scores from caregivers at midline, 24.1% at endline). We used the polytomous summary score of 183 
the WHODAS scaled from 0 to 100. 184 
Secondary outcomes 185 
• Experience of discrimination was measured using the ‘unfair treatment’ subscale of the 186 
discrimination and stigma scale-12 (DISC-12) (Brohan E et al., 2013). The original DISC-12 sub-187 
scale has 21 items. Four items lacked face validity or had a low frequency of endorsement, but 188 
the remaining 17 items loaded onto a single factor using exploratory factor analysis and were 189 
summed. 190 
• Restraint was measured by self-report of whether the person had been ‘restrained, chained or 191 
confined’ in the preceding 12 months. 192 
• Alcohol use disorder was measured using the lay interviewer-administered Alcohol Use Disorder 193 
Identification Test (AUDIT) (Babor TF et al., 2001). This 10-item scale has been adapted for local 194 
drinks in the Ethiopian setting. People scoring ≥8 are considered to have a probable alcohol use 195 
disorder. 196 
• Depression was measured using a locally validated version of the Patient Health Questionnaire 197 
(PHQ-9) (Kroenke and Spitzer, 2002). In the Ethiopian setting, a cut-off of 5 or more is indicative 198 
of major depressive disorder (Hanlon et al., 2015). 199 
• Suicide attempts in the past three months were assessed using the Mini International 200 
Neuropsychiatric Interview (Sheehan et al., 1997).  201 
Potential effect modifiers 202 
Equity indicators 203 
• Gender and residence (rural vs. urban).  204 
• Socio-economic status: a poverty index was constructed which loaded onto a unidimensional 205 
scale using exploratory factor analysis: roof material made of straw (vs. corrugated iron), 206 
unimproved water source, unimproved sanitation, no electricity, no separate room for kitchen, 207 
no radio or television, no mobile phone. 208 
• Time to access the nearest health facility, estimated in minutes, whatever the means of travel. 209 
This was dichotomised into less than 60 minutes vs. 60 minutes or longer.  210 
Baseline characteristic 211 
• Diagnosis: clinician-assessed diagnosis using criteria of the Diagnostic and Statistical Manual of 212 
the American Psychiatric Association, version IV) (American Psychiatric Association, 1994) from 213 
OPCRIT (McGuffin P et al., 1991). 214 
Process indicators  215 
• Receipt of minimally adequate treatment used the definition proposed by Wang et al. (Wang et 216 
al., 2002): prescription of medication on at least one occasion combined with at least four 217 
follow-up appointments with a health worker trained in mental health. We additionally required 218 
that psychotropic medication should be prescribed at therapeutic levels (World Health 219 
Organization, 2016). Data on the number of facility contacts and prescriptions were extracted 220 
from the clinical records, cross-referenced with a facility registration book.  221 
• Receipt of community support (measured at T1 and T2): support received with returning to 222 
work, remembering to take medication, improving self-care, meeting people and social 223 
engagement. Responses were summed and binarized: 0 to 2 types of community support vs. 3 224 
to 5 types of community support.  225 
• Receipt of in-patient care for mental health problems, contact with specialist mental health or 226 
general health facilities and traditional or religious healers, and type of care received during 227 
primary health care contacts were measured at T1 and T2.  228 
Descriptive baseline characteristics 229 
• Socio-demographic characteristics (age, educational level, marital status).  230 
• Social support was assessed using the three-item Oslo Social Support Scale (OSS-3) (Dalgard OS 231 
et al., 2006), which asks about number of close supports, extent of concern from supports and 232 
amount of practical support received. The OSS-3 total score was categorised as follows: 3 to 8 233 
“poor support”, 9 to 11 “intermediate support” and 12 to 14 “strong support”. 234 
• Duration of illness, type of illness onset (acute/sub-acute vs. gradual), psychiatric hospitalisation 235 
in the past 12 months, presence of co-morbid medical condition and receipt of psychotropic 236 
medication at baseline were obtained from the OPCRIT (McGuffin P et al., 1991). 237 
Data collection 238 
The lay interviewers were individuals with an educational level of at least tenth grade who were 239 
recruited from the local area and trained for 12 days on the study questionnaires and protocols, 240 
including observed practice interviews. The trainers had master’s level qualifications. Degree-level 241 
supervisors monitored data quality in the field. The clinician assessments were conducted by research 242 
psychiatric nurses who were trained for seven days by senior Ethiopian psychiatrists. The OPCRIT 243 
diagnoses were double-checked by an Ethiopian psychiatrist by reviewing the OPCRIT responses and 244 
clinical documentation and conducting verification interviews (n=2) where needed.   245 
Data management and analysis 246 
Data were double-entered using EpiData (Lauritsen and Bruus, 2003) and analysed using Stata version 247 
13.1 (StataCorp LP, 2016). The data were summarised descriptively, with outcome data stratified by 248 
equity indicators (gender, residence, distance from the health facility and poverty status). Comparison of 249 
the characteristics of participants remaining in the cohort with those lost to follow-up at 12 months, as 250 
well as by equity indicators, was conducted using Pearson chi-squared for categorical variables, 251 
Student’s t-test for comparing means in normally distributed variables and Kruskal Wallis equality-of-252 
populations rank test for non-normal continuous variables.  253 
Mixed effects linear regression with random intercept was used to model the change in symptom 254 
severity, disability and depressive symptoms over time. We tested for improvement in model fit using 255 
likelihood ratio tests after adding random slopes. We also tested for any significant difference in the 256 
mean change between T0 and T1 or between T1 and T2. Mixed effects ordinal regression was used to 257 
model change in discrimination score over time. A prevalence ratio was calculated for change from T0 to 258 
T2 in probable alcohol use disorder (AUDIT ≥ 8), suicide attempt in the preceding three months or 259 
restraint in the preceding 12 months.   260 
For the primary outcomes, we calculated standardised mean difference (Borenstein et al., 2009) and 261 
examined effect modification by the equity indicators, diagnosis (primary psychotic disorder vs. affective 262 
disorder), process indicators (receipt of minimally adequate treatment and community support) and by 263 
the community-based rehabilitation intervention group for the RISE trial. This was done by adding an 264 
interaction term into the model and testing for improved model fit using a likelihood ratio test. Multiple 265 
linear regression analysis was conducted to examine the association between baseline duration of 266 
illness and type of illness onset with 12 month outcomes. 267 
Ethical considerations 268 
Ethical approval was obtained from the Institutional Review Board of the College of Health Sciences, 269 
Addis Ababa University (No. 084/11/Psy). Informed consent was obtained where possible. If the person 270 
lacked capacity and did not refuse, the accompanying caregiver was invited to give permission on the 271 
person’s behalf.   272 
 273 
Results 274 
Of the 294 people diagnosed by PHC workers as having SMI, 279 were confirmed to have SMI, giving a 275 
positive predictive value for PHC worker diagnosis of 94.9%. A further 21 people referred by PHC 276 
workers to psychiatric nurses for diagnostic review were also found to have SMI, giving a total of 300 277 
participants. See Figure 1.  278 
 279 
  280 
Figure 1: Flow diagram 281 
 282 
Baseline characteristics 283 
See Table 1. At baseline there was no significant difference in symptom severity score, disability, 284 
discrimination or depressive symptoms by gender. The proportion with an alcohol use disorder (χ2(1) 285 
48.6750; p < 0.001) or who had been restrained (χ2(1) 5.1154; p=0.024) was higher in men. Baseline 286 
disability (t=2.1012; p=0.04) and restraint (χ2(1) 3.9058; p=0.048) were significantly higher in those with 287 
low socioeconomic status. Perceived negative discrimination at baseline was higher in urban residents 288 
(χ2(1) 3.986; p = 0.049) and people of low socioeconomic status (χ2(1) 4.195; p = 0.04).  289 
Cohort follow-up 290 
A total of 247 (82.3%) people were assessed at T1 (mean 7.4 months; SD 1.49) and 245 (81.7%) at T2 291 
(mean 12.3 months; SD 1.12). See Figure 1. There was no evidence of differential loss to follow-up based 292 
on baseline characteristics (Supplementary File 1). During the follow-up period, 11 participants died.    293 
Facility-based intervention 294 
After review by psychiatric nurses, the medication initiated by PHC workers was unchanged or changed 295 
within the same medication class for 184 (67.7%) participants. Psychiatric nurses increased the dose or 296 
added another medication for 46 (16.9%), stopped or reduced the dose in 15 (5.9%), changed the class 297 
of medication in 15 (5.5%) and stopped a prescription of depot antipsychotic medication in 5 (1.8%).  298 
Participants attended a median of two PHC appointments during the follow-up period (IQR 2,4; 299 
minimum 1 and maximum 12). Supplementary File 2. Minimally adequate treatment was received by 89 300 
(29.8%). Supplementary File 3. There was no evidence of prescribing above recommended limits and 301 
only one occurrence of antipsychotic polypharmacy. Admission for in-patient care was very low (1.4% at 302 
T1 and 2.0% at T2) and less than 10% of participants had direct contact with a mental health specialist. A 303 
high proportion reported receiving psychosocial support and explanation about medication 304 
(Supplementary File 4). 305 
Community-based interventions 306 
Most people with SMI reported receiving support with medication adherence and to improve self-care. 307 
More than half received support to get back to work, but less than a quarter were supported to get 308 
involved in social activities and less than 10% had support with meeting people. Almost all support was 309 
reported to come from the family. A small proportion reported contact with traditional or religious 310 
healers: 13.0% at T1 and 11.6% at T2.  311 
 312 
Impact on clinical and social outcomes 313 
There was a significant improvement in all clinical (symptom severity score, depressive symptoms, 314 
suicide attempts, alcohol use disorder) and social (functioning, discrimination, restraint). Tables 2 and 3. 315 
The standardised mean difference for symptom severity was 0.18 (95% confidence interval  (CI)) 0.02, 316 
0.34) between T0 and T1 and 0.28 (95%CI 0.13, 0.44) from T0 to T2. For disability, the standardised 317 
mean difference was larger at both time-points: T0 to T1: 0.27 (95%CI 0.13, 0.41), T0 to T2:  0.50 (95%CI 318 
0.35, 0.65). The test for interaction between the RISE trial intervention group and the main outcomes 319 
(symptom severity and functioning) at 12 months was non-significant.  320 
 321 
For symptom severity and functioning, the magnitude of the change did not differ between T0 and T1 322 
compared to T1 and T2. The reduction in depressive symptoms was significantly greater between T0 and 323 
T1 than between T1 and T2 (χ2(1) 4.26; p=0.039); similarly for change in perceived discrimination (χ2(1) 324 
3.75; p=0.053).  325 
There was no statistically significant effect modification by the equity indicators, diagnosis or process 326 
indicators for the primary outcomes. At T1, higher receipt of community support had a borderline 327 
statistical association with greater reduction in symptom severity (p=0.19) and disability (p=0.09). 328 
Supplementary Files 5 and 6. There was no association between duration of illness or type of illness 329 
onset and the mean improvement in the primary outcomes.  330 
 331 
Discussion 332 
In this community-ascertained intervention cohort of clinician-confirmed people with SMI, there was a 333 
significant improvement in clinical and social outcomes after implementation of a district level mental 334 
health care plan. PHC workers diagnosed SMI accurately, prescribed psychotropic medication safely and 335 
were reported to have delivered psychoeducation and provided support to most people with SMI. The 336 
findings from this study are generalizable to similar rural settings of low-income countries. 337 
Although PHC workers prescribed safely (low polypharmacy and no doses above the recommended 338 
therapeutic range), the psychiatric nurses did consider that it was necessary to change the initial 339 
prescriptions of psychotropic medication in 30.1% of cases. This reinforces the need for task-shared care 340 
to be supported by input by mental health specialists, either through regular supervision or through 341 
timely review of newly diagnosed cases.    342 
We are only aware of two previous studies, both from Nepal, where the impact of a ‘full’ task-sharing 343 
model on clinical and social outcomes of people with SMI was evaluated (Jordans et al., 2017, Jordans et 344 
al., 2019). Both studies found a significant reduction in symptom severity, disability and caregiver 345 
burden but had sample sizes under 100 and included extensive community-based psychosocial 346 
interventions (Jordans et al., 2019). Our larger study, which included a more representative population 347 
of people with SMI and a task-sharing intervention more closely based on mhGAP, provides more 348 
definitive evidence of important clinical and social benefits from the recommended WHO mhGAP 349 
approach.   350 
In our study, the impact of the district mental health care plan care on psychotic symptoms was less 351 
marked than the reductions seen in the social outcomes, with a reduction of 4.8 on the BPRSE being less 352 
than that usually considered to be clinically significant (Hanlon et al., 2016a). In previous intervention 353 
studies for people with SMI in LMIC settings, a key factor for clinical improvement has been enhanced 354 
adherence to antipsychotic medication (Chatterjee et al., 2014), but only 30% of people with SMI in our 355 
study received ‘minimally adequate treatment’ over the follow-up period. Our process data indicate that 356 
engagement waxed and waned over time, rather than people dropping out of care altogether, and lends 357 
support to the acceptability of care provided as well as providing explanation for the limited impact on 358 
symptom improvement at cross-sectional assessment. In-depth interviews with study participants with 359 
SMI who had disengaged from care indicated that most had experienced symptomatic improvement, 360 
but that affordability of medication and side effects of medications was a barrier to continuous 361 
engagement (Hailemariam et al., 2018). This is supported by quantitative data from the same sample, 362 
indicating high levels of poverty and out-of-pocket healthcare costs compared to the general population 363 
(Hailemichael et al., 2019). Mechanisms to reduce out-of-pocket healthcare costs for people with SMI 364 
are needed to achieve improved access to mental health care (Hanlon, 2019).  365 
Although disability is closely linked to symptom severity, our previous work in this community indicates 366 
that stigma, discrimination and poverty also make important contributions (Habtamu et al., 2018). The 367 
borderline significant effect modification indicating greater improvements in disability in people with 368 
higher receipt of community support may reflect the impact of reduced social exclusion. We observed a 369 
significant decline in perceived negative discrimination in people with SMI. The PRIME mental health 370 
care plan included a cascade model of training of community-based health extension workers to raise 371 
community awareness and reduce stigma against mental health problems (Fekadu et al., 2016); 372 
however, the extent of implementation is not known. The growing community and family awareness of 373 
the treatability of SMI, arising from the local availability of a treatment service and bearing witness to 374 
the clinical improvement of people with SMI who were well-known to the community, might have also 375 
reduced stigmatising attitudes, social exclusion and the need for people to be restrained (Hailemariam 376 
et al., 2018). Furthermore, the Community Advisory Board members were selected due to their level of 377 
community influence and their endorsement of mental health care helped to reduce stigma and 378 
misconceptions about mental illness in the study site. In a recent trial in Ghana, restraint was not 379 
reduced by short-term provision of psychiatric care to people with SMI who were receiving faith healing 380 
in prayer camps (Ofori-Atta et al., 2018). In our study, the follow-up period was longer, which may have 381 
allowed family members and the community to gain confidence in the beneficial effects of treatment 382 
and the PRIME intervention incorporated community and system level interventions as well as task-383 
shared facility-based care.   384 
Alternative approaches to expanding access to care for people with SMI in rural populations in LMICs 385 
have been reported. One model is to utilise outreach clinics staffed by mental health specialists who 386 
diagnose, prescribe and monitor clinical progress, combined with community-level interventions by non-387 
specialists to promote social inclusion and functional recovery (Chatterjee et al., 2014, Chatterjee et al., 388 
2009, Srinivasa Murthy et al., 2005). Another ‘back-referral’ model is for mental health specialists to 389 
provide initial assessment and development of a care plan which is then implemented by non-specialist 390 
health workers in the local area combined with task-shared psychosocial interventions (Xiang M et al., 391 
1994). Augmenting the PRIME model with more intensive and systematic community-based 392 
rehabilitation delivered by non-specialists may help to address some of the gaps identified in our study 393 
by strengthening engagement with PHC and supporting livelihoods (Asher et al., 2016), although the 394 
affordability and sustainability of such approaches needs evaluation. There are no published reports of 395 
these task-sharing service models being successfully, safely and sustainably taken to scale and we have 396 
no evidence regarding their relative impact on effective treatment coverage for people with SMI. In the 397 
future, randomised controlled trials comparing task-shared models of care for people with SMI are 398 
needed to inform policy decisions (Hanlon et al., 2016a). 399 
Limitations 400 
PHC workers were informed of the research psychiatric nurse diagnosis and changes in treatment plan. 401 
For diagnosis the concordance was high and so this is unlikely to have affected the outcome, but the 402 
treatment plan reflected task-shared care with support from a mental health specialist.. We only 403 
collected data on the positive and not the negative predictive value of the PHC worker diagnosis. 404 
Calculating the negative predictive value would be an important focus for future studies. Due to ethical 405 
concerns, there was no comparison group of people with SMI receiving ‘usual care’, which would have 406 
amounted to no access to evidence-based care for most people. However, outcomes in people with 407 
untreated schizophrenia (who formed the majority of our cohort) have been shown to be poor (Ran et 408 
al., 2001). Given the chronicity and severity of SMI at baseline, spontaneous improvement is unlikely. 409 
This is supported by the lack of an association between baseline duration of illness or type of illness 410 
onset and outcomes in our study.  411 
Conclusions 412 
An integrated district level mental health care plan employing a task-sharing approach safely addressed 413 
the large treatment gap for people with SMI in a rural, low-income country setting, resulting in 414 
improved clinical and social outcomes and reduced human rights abuses. Training and supporting PHC 415 
workers to provide mental health care has great potential as a sustainable and feasible approach to the 416 
care of people with SMI in resource-poor settings.    417 
 418 
419 
Table 1: Baseline characteristics of the severe mental disorder cohort stratified by gender 420 
Characteristics Total 
N (%) 
Male 
N (%) 
Female 
N (%) 
300 (100.0) 172 (57.3) 128 (42.7) 
Age (years) Mean (Standard Deviation) 35.5 (13.45) 36.6 (12.86) 34.1 (14.1) 
Educational level 
(n=299) 
 
No formal education 
Primary education 
Secondary and above 
157 (52.5) 
112 (37.5) 
30 (10.0) 
79 (46.2) 
75 (43.9) 
17 (9.9) 
78 (60.9) 
37 (28.9) 
13 (10.2) 
Religious affiliation 
  
Orthodox Christian 
Muslim 
Protestant Christian 
None 
270 (90.0) 
10 (3.3) 
19 (6.3) 
1 (0.3) 
154 (89.5) 
7 (4.1) 
10 (5.8) 
1 (0.6) 
116 (90.6) 
3 (2.3) 
9 (7.0) 
0 (0.0) 
Ethnicity 
 
Gurage 
Other 
284 (94.7) 
16 (5.3) 
162 (94.2) 
10 (5.8) 
122 (95.3) 
6 (4.7) 
Marital status 
 
Married 
Single 
Divorced or widowed 
111 (37.0) 
136 (45.3) 
53 (17.7) 
66 (38.4) 
83 (48.3) 
23 (13.4) 
45 (35.2) 
53 (41.1) 
30 (23.4) 
Household size 
(n=298) 
 
1 to 2 
3 to 4 
5 to 6 
7 or more 
34 (11.4) 
85 (28.5) 
92 (30.9) 
87 (29.2) 
19 (11.1) 
46 (26.9) 
47 (27.5) 
59 (34.5) 
15 (11.8) 
39 (30.7) 
45 (35.4) 
28 (22.1) 
Children in household 
(n=287) 
 
None 
≤ 5 years 
5 to 15 years 
16 years and older 
138 (48.1) 
67 (23.3) 
58 (20.2) 
24 (8.4) 
89 (54.3) 
33 (20.1) 
35 (21.3) 
7 (4.3) 
49 (39.8) 
34 (27.6) 
23 (18.7) 
17 (13.8) 
Socio-economic status 
(n=297) 
Higher (poverty index ≤ 3) 
Lower (poverty index >3) 
177 (59.6) 
120 (40.4) 
100 (58.5) 
71 (41.5) 
77 (61.1) 
49 (38.9) 
Residence  
(n=299) 
Urban 
Rural 
60 (20.1) 
239 (79.9) 
36 (20.9) 
136 (79.1) 
24 (18.9) 
103 (81.1) 
Social support 
(n=298) 
 
Strong social support 
Intermediate support 
Poor support 
56 (18.8) 
151 (50.7) 
91 (30.5) 
31 (18.2) 
83 (48.8) 
56 (32.9) 
25 (19.5) 
68 (53.1) 
35 (27.3) 
Travel time to nearest 
health facility (n=299) 
≤ 60 minutes 
61 to 120 minutes 
≥121 minutes 
192 (64.2) 
60 (20.1) 
47 (15.7) 
115 (67.3) 
32 (18.7) 
24 (14.0) 
77 (60.2) 
28 (21.9) 
23 (18.0) 
Diagnosis 
 
Affective psychosis/bipolar disorder 
Schizophrenia & other psychoses 
44 (14.7) 
256 (85.3) 
21 (12.2) 
151 (87.8) 
23 (18.0) 
105 (82.0) 
Duration of illness 
(years) (n=270) 
Median (Interquartile range; IQR) 5 (2.8, 10) 5 (2.8, 10) 5.5 (2.8, 11) 
Onset of illness 
(n=271) 
Acute/sub-acute 
Gradual 
100 (36.9) 
171 (63.1) 
55 (35.5) 
100 (64.5) 
45 (38.8) 
71 (61.2) 
Psychiatric admission In past 12 months 11 (3.7) 5 (2.9) 6 (4.7) 
Treatment at 
recruitment (n=261) 
Prescribed medication at baseline 69 (26.4) 
 
35 (23.5) 34 (30.4) 
Co-morbid medical 
disorder (n=286) 
Diagnosed medical condition 18 (6.3) 13 (8.1) 5 (4.0) 
*Poverty index = roof material made of straw (vs. corrugated iron), unimproved water source, unimproved sanitation, no 421 
electricity, no separate room for kitchen, no radio or television, no mobile ‘phone.  422 
423 
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Table 2:  Mixed effects modelling of primary outcomes stratified by equity indicators  424 
Outcome Baseline 
(T0) 
Mean (SD) 
T0 to T1 mean 
difference (95% 
confidence intervals 
T0 to T2 mean 
difference (95% 
confidence intervals 
 
SMI symptoms (BPRS-E) 
 
N=294 
 
N=247 
 
N=245 
Total sample 
 
48.5 (15.6) -2.6 (-4.8,-0.4) -4.8 (-7.0, -2.6) 
Gender  Male 47.9 (16.3) -2.2 (-5.2, 0.9) -3.9 (-6.9, -0.8) 
Female 49.4 (14.7) -3.2 (-6.3, -0.04) -6.0 (-9.1, -2.8) 
Residence Urban 47.4 (16.5) -4.0 (-9.3, 1.2) -9.0 (-14.2, -3.8) 
Rural 48.9 (15.4) -2.3 (-4.7, 0.1) -4.1 (-6.5, -1.7) 
Health care 
access 
<60 minutes 48.2 (16.2) -2.1 (-4.8, -0.7) -5.5 (-8.3, -2.8) 
≥ 60 minutes 49.3 (15.6) -3.9 (-7.5, -0.3) -3.4 (-7.0, 0.3) 
Socio-economic 
status 
Higher 49.2 (16.0) -3.5 (-6.6, -0.5) -5.6 (-8.6, -2.5) 
Lower 47.4 (15.1) -0.8 (-3.9, 2.4) -3.1 (-6.2, -0.02) 
 
Disability (WHODAS 2.0) 
 
N=296 
 
N=246 
 
N=245 
Total sample 
 
52.2 (22.0) -6.2 (-9.3, -3.1) -12.0 (-15.1, -8.9) 
Gender  Male 52.3 (21.5) -7.8 (-11.8, -3.8) -10.1 (-14.2, -6.0) 
Female 52.1 (22.7) -4.2 (-9.0, 0.6) -14.3, (-19.1, -9.6) 
Residence Urban 49.2 (22.3) -7.4 (-14.0, -0.7) -14.1 (-20.6, -7.5) 
Rural 53.1 (21.9) -6.2 (-9.7, -2.7) -11.8 (-15.3, -8.2) 
Health care 
access 
<60 minutes 50.4 (22.5) -4.8 (-8.7, -0.8) -11.4 (-15.3, -7.4) 
≥ 60 minutes 55.9 (20.7) -8.9 (-13.9, -3.8) -13.4 (-18.5, -8.3) 
Socio-economic 
status 
Higher 50.0 (21.8) -6.9 (-11.1, -2.7) -11.4 (-15.6, -7.2) 
Lower 55.3 (22.1) -4.7 (-9.3, -0.1) -12.4 (-17.0, -7.9) 
 425 
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Table 3: Secondary clinical and social outcomes in people with SMI stratified by gender 427 
Outcome Baseline (T0) Follow-up (T2) T0 to T2 change 
 Mean (SD) Mean (SD) Mean difference 
Depression symptoms (PHQ-9) N=300 N=245  
Total sample 12.8 (5.43) 7.2 (4.80) -5.6 (-6.3, -4.8) 
Male 12.9 (5.64) 7.4 (4.84) -5.4 (-6.5, -4.4) 
Female 12.8 (5.15) 7.0 (4.75) -5.7 (-6.8, -4.6) 
 Median (IQR) Median (IQR) Odds ratio 
Discrimination (DISC-12) N=300 N=245  
Total sample 2 (0, 7) 0 (0, 3) 0.4 (0.3, 0.5) 
Male 2 (0, 7) 0 (0, 4) 0.5 (0.3, 0.8) 
Female 3 (0, 7) 0 (0, 2) 0.2 (0.1, 0.4) 
 N (%) N (%) Prevalence ratio 
Alcohol use disorder (AUDIT≥8) N=300 N=245  
Total sample 87 (29.0) 40 (16.3) 0.6 (0.5, 0.8) 
Male 77 (44.8) 34 (25.2) 0.6 (0.4, 0.8) 
Female 10 (7.8) 6 (5.5) 0.7 (0.3, 1.4) 
Suicide attempts past 3 months N=300 N=245  
Total sample 42 (14.0) 12 (4.9) 0.3 (0.2, 0.6) 
Male 20 (11.6) 8 (5.9) 0.5 (0.2, 1.0) 
Female 22 (17.2) 4 (3.6) 0.2 (0.1, 0.5) 
Restrained past 12 months N=300 N=245  
Total sample 76 (25.3) 26 (10.6) 0.4 (0.3, 0.6) 
Male 52 (30.2) 13 (9.6) 0.3 (0.2, 0.5) 
Female 24 (18.8) 13 (11.8) 0.6 (0.3, 1.0) 
 428 
 429 
430 
24 
 
 References 431 
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (4th 432 
Edition) (DSM-IV). APA: Washington, DC. 433 
Asher L, De Silva M, Hanlon C, Weiss HA, Birhane R, Ejigu DA, Medhin G, Patel V, Fekadu A (2016). 434 
Community-based Rehabilitation Intervention for people with Schizophrenia in Ethiopia (RISE): 435 
study protocol for a cluster randomised controlled trial. Trials 17, 299. DOI 210.1186/s13063-436 
13016-11427-13069. 437 
Babor TF, Higgins-Biddle JC, Saunders JB, MG. M (2001). The alcohol use disorders identification test: 438 
guidelines for use in primary care. 2nd ed. World Health Organizarion: Geneva. 439 
Baron EC, Rathod SD, Hanlon C, Prince M, Fedaku A, Kigozi F, Jordans M, Luitel NP, Medhin G, Murhar 440 
V, Nakku J, Patel V, Petersen I, Selohilwe O, Shidhaye R, Ssebunnya J, Tomlinson M, Lund C, De 441 
Silva M (2018). Impact of district mental health care plans on symptom severity and functioning 442 
of patients with priority mental health conditions: the Programme for Improving Mental Health 443 
Care (PRIME) cohort protocol. BMC Psychiatry 18, 61. 444 
Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009). Chapter 4: Effect sizes based on means. In 445 
Introduction to meta-analysis. John Wiley & Sons, Ltd. 446 
Brohan E, Clement S, Rose D, Sartorius N, Thornicroft G (2013). Development and psychometric 447 
evaluation of the Discrimination and Stigma Scale (DISC). Psychiatry Research 208, 33-40. 448 
Burlingame GM, Seaman S, Johnson JE, Whipple J, Richardson E, Rees F, Earnshaw D, Spencer R, Payne 449 
M, O'Neil B (2006). Sensitivity to change of the Brief Psychiatric Rating Scale - Extended (BPRS-450 
E): an item and subscale analysis. Psychological Services 3, 77-87. 451 
Chatterjee S, Naik S, John S, Dabholkar H, Balaji M, Koschorke M, Varghese M, Thara R, Weiss HA, 452 
Williams P, McCrone P, Patel V, Thornicroft G (2014). Effectiveness of a community-based 453 
intervention for people with schizophrenia and their caregivers in India (COPSI): a randomised 454 
controlled trial.[Erratum appears in Lancet. 2014 Jun 14;383(9934):2046]. Lancet 383, 1385-455 
1394. 456 
Chatterjee S, Pillai A, Jain S, Cohen A, Patel V (2009). Outcomes of people with psychotic disorders in a 457 
community-based rehabilitation programme in rural India. British Journal of Psychiatry 195, 433-458 
439. 459 
Dalgard OS, Dowrick C, Lehtinen V, Vazquez-Barquero JL, Casey P, Wilkinson G, Ayuso-Mateos JL, Page 460 
H, Dunn G (2006). Negative life events, social support and gender difference in depression: a 461 
multinational community survey with data from the ODIN study. Social Psychiatry & Psychiatric 462 
Epidemiology 41, 444-451. 463 
Fekadu A, Hanlon C, Medhin G, Alem A, Selamu M, Giorgis T, Shibre T, Teferra S, Tegegn T, Breuer E, 464 
Patel V, Tomlinson M, Thornicroft G, Prince M, Lund C (2016). Development of a scalable 465 
mental healthcare plan for a rural district in Ethiopia. British Journal of Psychiatry Supplement 466 
208, s4-s12. 467 
Fekadu A, Hanlon C, Thornicroft G, Lund C, Kaaya S, Alem A, Gureje O, Cleare AJ, Patel V, Prince MJ 468 
(2015). Care for bipolar disorder in LMICs needs evidence from local settings. The Lancet 469 
Psychiatry 2, 772-773. 470 
Gureje O, Abdulmalik J, Kola L, Musa E, Yasamy MT, Adebayo K (2015). Integrating mental health into 471 
primary care in Nigeria: report of a demonstration project using the mental health gap action 472 
programme intervention guide. BMC health services research 15, 242-242. 473 
Habtamu K, Alem A, Medhin G, Fekadu A, Dewey M, Prince M, Hanlon C (2017). Validation of the 474 
World Health Organization Disability Assessment Schedule in people with severe mental 475 
disorders in rural Ethiopia. Health and Quality of Life Outcomes 15, 64. 476 
25 
 
Habtamu K, Alem A, Medhin G, Fekadu A, Hanlon C (2018). Functional impairment among people with 477 
severe and enduring mental disorder in rural Ethiopia: a cross-sectional study. Social Psychiatry 478 
& Psychiatric Epidemiology, http://dx.doi.org/10.1007/s00127-00018-01546-00126. 479 
Hailemariam M, Fekadu A, Medhin G, Prince M, Hanlon C (2018). Equitable access to mental healthcare 480 
integrated in primary care for people with severe mental disorders in rural Ethiopia: a 481 
community-based cross-sectional study Under review. . 482 
Hailemariam M, Fekadu A, Selamu M, Alem A, Medhin G, Wolde Giorgis T, DeSilva M, Breuer E (2015). 483 
Developing a mental health care plan in a low resource setting: the theory of change approach. 484 
BMC Health Services Research 15, 429: DOI 410.1186/s12913-12015-11097-12914. 485 
Hailemichael Y, Hailemariam D, Tirfessa K, Docrat S, Alem A, Medhin G, Lund C, Chisholm D, Fekadu A, 486 
Hanlon C (2019). Catastrophic out-of-pocket payments for households of people with severe 487 
mental disorder: a comparative study in rural Ethiopia. International Journal of Mental Health 488 
Systems 13, 39. https://doi.org/10.1186/s13033-13019-10294-13037. 489 
Hanlon C, Alem A, Medhin G, Shibre T, Ejigu DA, Negussie H, Dewey M, Wissow L, Prince M, Susser E, 490 
Lund C, Fekadu A (2016a). Task sharing for the care of severe mental disorders in a low-income 491 
country (TaSCS): study protocol for a randomised, controlled, non-inferiority trial. Trials 17, 76  492 
doi:10.1186/s13063-13016-11191-x. 493 
Hanlon C, Alem, A., Lund, C., Hailemariam, D., Assefa, E., Giorgis, T. W., Chisholm, D. (2019). Moving 494 
towards universal health coverage for mental disorders in Ethiopia. International Journal of 495 
Mental Health Systems 13, 11. https://doi.org/10.1186/s13033-13019-10268-13039. 496 
Hanlon C, Fekadu A, Jordans M, Kigozi F, Peterson I, Shidhaye R, Honikman S, Lund C, Prince M, Raja S, 497 
Thornicroft G, Tomlinson M, Patel V (2016b). District Mental Health Care Plans for five low- and 498 
middle-income countries: commonalities, variations and evidence gaps. British Journal of 499 
Psychiatry Supplement 208, s47-s54. 500 
Hanlon C, Luitel NP, Kathree T, Murhar V, Shrivasta S, Medhin G, Ssebunnya J, Fekadu A, Shidhaye R, 501 
Petersen I, Jordans M, Kigozi F, Thornicroft G, Patel V, Tomlinson M, Lund C, Breuer E, De Silva 502 
M, Prince M (2014). Challenges and Opportunities for Implementing Integrated Mental Health 503 
Care:  A District Level Situation Analysis from Five Low- and Middle-Income Countries. PLoS One 504 
9, e88437. 505 
Hanlon C, Medhin G, Selamu M, Breuer E, Worku B, Hailemariam M, Lund C, Prince M, Fekadu A 506 
(2015). Validity of brief screening questionnaires to detect depression in primary care in 507 
Ethiopia. Journal of Affective Disorders 186, 32-39. 508 
Jordans MJD, Aldridge L, Luitel NP, Baingana F, Kohrt BA (2017). Evaluation of outcomes for psychosis 509 
and epilepsy treatment delivered by primary health care workers in Nepal: a cohort study. 510 
International Journal of Mental Health Systems 11, 70. 511 
Jordans MJD, Luitel NP, Kohrt BA, Rathod SD, Garman EC, De Silva M, Komproe IH, Patel V, Lund C 512 
(2019). Community-, facility-, and individual-level outcomes of a district mental healthcare plan 513 
in a low-resource setting in Nepal: A population-based evaluation. PLOS Medicine 16, e1002748. 514 
Kroenke K, Spitzer RL (2002). The PHQ-9: A new depression diagnostic and severity measure. Psychiatric 515 
Annals 32, 509-515. 516 
Lauritsen JM, Bruus M (2003). Epidata (Version 3). A comprehensive tool for validated entry and 517 
documentation of data. . The Epidata Association,: Odense, Denmark,. 518 
McGuffin P, Farmer AE, Harvey I (1991). A polydiagnostic application of operational criteria in studies of 519 
psychotic illness: development and reliability of the OPCRIT system. Archives of General 520 
Psychiatry 48, 764-770. 521 
Ofori-Atta A, Attafuah J, Jack H, Baning F, Rosenheck R (2018). Joining psychiatric care and faith healing 522 
in a prayer camp in Ghana: randomised trial. The British Journal of Psychiatry 212, 34-41. 523 
26 
 
Ran MS, Xiang MZ, Huang MS, Shan YH (2001). Natural course of schizophrenia: 2-year follow-up study 524 
in a rural Chinese community. British Journal of Psychiatry 178, 154-158. 525 
Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Janavs J, Weiller E, Bonara LI, Keskiner A, Schinka J, 526 
Knapp E, Sheehan MF, Dunbar GC (1997). Reliability and Validity of the MINI International 527 
Neuropsychiatric Interview (M.I.N.I.): According to the SCID-P. European Psychiatry 12, 232-241. 528 
Shibre T, Kebede D, Alem A, Negash A, Kibreab S, Fekadu A, Fekadu D, Jacobsson L, Kullgren G (2002). 529 
An evaluation of two screening methods to identify cases with schizophrenia and affective 530 
disorders in a community survey in rural Ethiopia. International Journal of Social Psychiatry 48, 531 
200-208. 532 
Srinivasa Murthy R, Kishore Kumar KV, Chisholm D, Thomas T, Sekar K, Chandrashekar CR (2005). 533 
Community outreach for untreated schizophrenia in rural India: a follow-up study of symptoms, 534 
disability, family burden and costs. Psychological Medicine 35, 341-351. 535 
StataCorp LP (2016). Stata version 13.1. Texas, USA. 536 
Üstün TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, Saxena S, von Korffe M, Pullf 537 
C, in collaboration with WHO/NIH Joint Project (2010). Developing the World Health 538 
Organization Disability Assessment Schedule 2.0. Bulletin of the World Health Organization 88, 539 
815-823. 540 
Ventevogel P, van de Put W, Faiz H, van Mierlo B, Siddiqi M, Komproe IH (2012). Improving Access to 541 
Mental Health Care and Psychosocial Support within a Fragile Context: A Case Study from 542 
Afghanistan. PLOS Medicine 9, e1001225. 543 
Wang PS, Angermeyer M, Borges G, Bruffaerts R, Chiu WT, de Girolamo G, Fayyad J, Gureje O, Haro 544 
JM, Huang Y, Kessler, R. C.,, Kovess V, Levinson D, Nakane Y, Brown M. A. O., Ormel JH, 545 
Posada-Villa J, Aguilar-Gaxiola S, Alonso J, Lee S, Heering S, Pennell B-E, Chatterji S, Ustun TB, 546 
for the WHO World Mental Health Survey Consortium (2007). Delay and failure in treatment 547 
seeking after first onset of mental health disorders in the World Health Organization's World 548 
Mental Health Survey Initiative. World Psychiatry 6, 177-185. 549 
Wang PS, Demler O, Kessler RC (2002). Adequacy of Treatment for Serious Mental Illness in the United 550 
States. American Journal of Public Health 92, 92-98. 551 
World Health Organization (2008). Mental Health Gap Action Programme (mhGAP): Scaling up care for 552 
mental, neurological, and substance use disorders. WHO: Geneva. 553 
World Health Organization (2016). Mental Health Gap Action Programme Intervention Guide (mhGAP-554 
IG) for mental, neurological and substance use disorders in non-specialized health settings, 555 
version 2.0. WHO: Geneva. 556 
Xiang M, Ran M, Li S (1994). A controlled evaluation of psychoeducational family intervention in a rural 557 
Chinese community. British Journal of Psychiatry 154, 544-548. 558 
 559 
560 
27 
 
Required statements 561 
Acknowledgements 562 
We would like to express our thanks to the study participants for generously giving their time and 563 
energy to complete interviews, and to the field staff who worked tirelessly to ensure the smooth 564 
running of the project.  565 
 566 
Financial support 567 
This study was funded by the UK Department for International Development (DfID) [201446], as part of 568 
the Programme for Improving Mental health care (PRIME). The views expressed in this article do not 569 
necessarily reflect the UK Government’s official policies. CH is supported by the National Institute of 570 
Health Research (NIHR) Global Health Research Unit on Health System Strengthening in Sub-Saharan 571 
Africa, King’s College London (GHRU 16/136/54). The views expressed are those of the author and not 572 
necessarily those of the NHS, the NIHR or the Department of Health and Social Care. CH, CL, VP, AF and 573 
GM are supported by PRIME. CH additionally receives support from AMARI as part of the DELTAS Africa 574 
Initiative [DEL-15-01]. GT is supported by the National Institute for Health Research (NIHR) Collaboration 575 
for Leadership in Applied Health Research and Care South London at King’s College London NHS 576 
Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, 577 
the NIHR or the Department of Health. GT acknowledges financial support from the Department of 578 
Health via the National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia 579 
Unit awarded to South London and Maudsley NHS Foundation Trust in partnership with King’s College 580 
London and King’s College Hospital NHS Foundation Trust. GT is supported by the European Union 581 
Seventh Framework Programme (FP7/2007-2013) Emerald project. GT also receives support from the 582 
National Institute of Mental Health of the National Institutes of Health under award number 583 
28 
 
R01MH100470 (Cobalt study). GT is also supported by the UK Medical Research Council in relation the 584 
Emilia (MR/S001255/1) and Indigo Partnership (MR/R023697/1) awards. LA was supported by a 585 
Wellcome Trust Fellowship in International Health [grant number 100142/Z/12/Z].  586 
 587 
Conflict of interest 588 
None. 589 
Ethical standards 590 
The authors assert that all procedures contributing to this work comply with the ethical standards of the 591 
relevant national and institutional committees on human experimentation and with the Helsinki 592 
Declaration of 1975, as revised in 2008. 593 
Availability of Data and Materials 594 
The datasets used and/or analysed during the current study are available from the corresponding author 595 
on reasonable request. The PRIME datasets will be made publicly available during 2019 (via 596 
www.prime.uct.ac.za). 597 
 598 
 599 
Supporting information captions 600 
Supplementary file 1 601 
File format: WORD 602 
Title: Characteristics of participants assessed at 12 months compared to those lost to follow-up 603 
29 
 
Description: Table displaying baseline characteristic of people with SMI who were re-assessed at the 12-604 
month follow-up time-point compared to those who were lost to follow-up. 605 
Supplementary file 2 606 
File format: WORD (embedded tiff figure). 607 
Title: Pattern of engagement with primary care mental health care 608 
Description: Figure showing number of primary care contacts for mental health care for each 3 month 609 
period of follow-up. 610 
Supplementary file 3 611 
File format: WORD 612 
Title: Psychotropic medication prescribed to cohort participants 613 
Description: Descriptive summary of % of people receiving different types of psychotropic medication. 614 
Supplementary file 4 615 
File format: WORD 616 
Title: Receipt of community and facility level care over the follow-up period 617 
Description: Types of care received by the participants over the 12 month follow-up period. 618 
Supplementary file 5 619 
File format: WORD 620 
Title: Tests for effect modification of change in outcome variables between T0 and T1 621 
Description: Table presenting statistical testing of effect modification between T0 and T1.  622 
Supplementary file 6 623 
30 
 
File format: WORD 624 
Title: Tests for effect modification of change in outcome variables between T0 and T2 625 
Description: Table presenting statistical testing of effect modification between T0 and T2. 626 
Supplementary file 7 627 
File format: WORD 628 
Title: STROBE checklist 629 
Description: STROBE checklist for reporting of this study 630 
631 
31 
 
Figure 1: flow chart of study participants 632 
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